Locations:
SearchWelcome to the new spotlight edition of Cancer Advances, exploring the latest research and clinical advances in hematology and oncology.
Phase 2 study brings pivotal advances in treatment efficacy and safety for the most challenging-to-treat population
Advertisement
Early results show patients experiencing deep and complete response
Combination therapy doubles the number of meaningful spleen volume responses over monotherapy
Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities
Uterine transposition cleared the field for radiation therapy
Growing need for addressing fertility concerns
Simple score uses clinical factors to identify patients who might benefit from earlier screening
Integrated care model reduces length of stay, improves outpatient pain management
Radiation therapy produces anti-inflammatory response
Patient receives liver transplant and a new lease on life
Novel approach begins reinnervation before tumor resection, preserving a young woman’s smile
Patient with cerebral palsy undergoes life-saving tumor resection
Patient with TP53 mutation achieves full response with targeted therapy
Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy
A multi-pronged strategy for tackling cancer access problems
Psychosocial oncology offers a path forward
National Blood Clot Alliance collaborates with faith-based organizations on first-of-its-kind church bus tour
Program reduces major contour changes and variations in organ-at-risk dosing across health system
Best practices for reducing toxicities
Ultra-Hypofractionated Whole Breast Irradiation and Partial Breast Irradiation Reduce Many Toxicities
Reconsidering axillary lymph node dissection as well as depth of surgical margins
Cleveland Clinic, the University of Minnesota and University of Cambridge receive $1M grant to develop point-of-care biosensor for early detection and treatment personalization
AI histologic classifier reliably predicts clinical risk in men post-prostatectomy
Personalized reconstruction is an alternative to leg amputation or flail limb
International study supports change in clinical care in post-neoadjuvant setting
Advertisement
Advertisement